D. S. Dodd, Y. Zhao / Tetrahedron Letters 42 (2001) 1259–1262
1261
Table 2.
Puritya,b
NH
(5 R1=2,6-dichlorobenzyl)
Entry
(3)
R3
Product
R2
Cl
NH2
O
(5g)
(5h)
NH3
(3a)
1
85%
N
H2N
Cl
Cl
NH2
N
O
(3b)
n-PrNH2
>95%
2
N
H
Cl
Cl
NH2
O
(3c)
(3d)
i-PrNH2
allylNH2
(5i)
(5j)
3
4
>95%
>95%
N
N
H
Cl
Cl
NH2
N
O
N
H
Cl
Cl
NH2
N
O
(CH3)2NH
aniline
(3e)
(3f)
(5k)
(5l)
5
6
>95%
90%
N
Cl
Cl
NH2
N
O
N
H
Cl
aHPLC purity is of the crude material after cleavage and determined by evaporative light scattering (ELS); peak
identity based on LC/MS analysis. bCrude yield ranged from 75-85%, as the TFA salt, based on 100% loading
of the p-nitrophenylcarbonate resin.
References
Comb. Chem. 2000, 2, 383; (c) Dolle, R. E.; Nelson, Jr., K.
H. J. Comb. Chem. 1999, 1, 235.
1. (a) In Guanidino Compounds in Biology and Medicine: 2;
De Deyn, P.; Marescau, B.; Qureshi, I. A.; Mori, A., Eds.;
John Libbey: London, 1997; (b) Greenhill, J. L.; Lue, P. In
Progress in Medicinal Chemistry; Ellis, G. P.; Luscombe,
D. K., Eds.; Elsevier Science: New York, 1993; Vol. 30,
Chapter 5; (c) In Guanidino Compounds in Biology and
Medicine; De Deyn, P.; Marescau, B.; Stalon, V.; Qureshi.
I. A., Eds.; John Libbey: London, 1992.
2. (a) Yamamoto, T.; Hori, M.; Watanabe, I.; Tsutsui, H.;
Harada, K.; Ikeda, S.; Maruo, J.; Morita, T.; Ohtaka, H.
Chem. Pharm. Bull. 1997, 45, 1975; (b) Scholz, W.; Albus,
U.; Counillon, L.; Go¨gelein, H.; Lang, H.-J.; Linz, W.;
Weichert, A.; Scho¨lkens, B. A. Cardiovasc. Res. 1995, 29,
260; (c) Baumgarth, M.; Beier, N.; Gericke, R. J. Med.
Chem. 1997, 40, 2017 and references cited therein; (d)
Adang, A. E. P.; Lucas, H.; De Man, A. P. A.; Engh, R.
A.; Grootenhuis, P. D. J. Bioorg. Med. Chem. Lett. 1998,
8, 3603; (e) Thomas, E. W.; Nishizawa, E. E.; Zimmer-
mann, D. C.; Williams, D. J. J. Med. Chem. 1989, 32, 228;
(f) Ahmad, S.; Wu, S. C.; Atwal, K. S.; Duggar, S. PCT
Int. Appl. WO 9933460, 1999; (g) Durant, G. J.; Padman-
abahan, S. PCT Int. Appl. WO 9920599, 1999.
4. (a) Pa´tek, M.; Smrcina, M.; Nakanishi, E.; Izawa, H. J.
Comb. Chem. 2000, 2, 370; (b) Wilson, L. J.; Klopfenstain,
S. R.; Li, M. Tetrahedron Lett. 1999, 40, 3999; (c) Yong,
Y. F.; Kowalski, J. A.; Thoen, J. C.; Lipton, M. A.
Tetrahedron Lett. 1999, 40, 53; (d) Dodd, D. S.; Wallace,
O. B. Tetrahedron Lett. 1998, 39, 5701; (e) Kearney, P. C.;
Fernandez, M.; Flygare, J. A. Tetrahedron Lett. 1998, 39,
2663; (f) Schneider, S. E.; Bishop, P. A.; Salazar, M. A.;
Bishop, O. A.; Anslyn, E. V. Tetrahedron 1998, 54, 15063;
(g) Drewry, D. H.; Gerritz, S. W.; Linn, J. A. Tetrahedron
Lett. 1997, 38, 3377; (h) Robinson, S.; Roskamp, E. J.
Tetrahedron 1997, 53, 6697.
5. (a) Josey, J. A.; Tarlton, C. A.; Payne, C. E. Tetrahedron
Lett. 1998, 39, 5899 (this protocol requires pre-assembly of
N-acylthioureas, as the latent guanidines, in solution prior
to immobilization to the solid support, further limiting
diversity); (b) Lin, P.; Ganesan, A. Tetrahedron Lett. 1998,
39, 9789.
6. ACD(Available Chemical Directory); MDL Information
Systems, San Leandro, CA, USA.
7. p-Nitrophenylcarbonate resin was prepared from Wang
resin according to the procedure of Ho, C. Y.; Kukla, M.
J. Tetrahedron Lett. 1997, 38, 2799.
3. (a) In Combinatorial Chemistry and Molecular Diversity in
Drug Discovery; Gordon, E. M.; Kerwin Jr., J. F., Eds.;
Wiley-Liss Inc: New York, NY, 1998; (b) Dolle, R. E. J.
8. Typical procedure: A mixture of p-nitrophenylcarbonate
resin6 (2.5 g, 1.1 mmol/g, 2.75 mmol), S-methylisothiouro-